On July 22, Quantinuum rose 5.24% overnight, trading at $61.65/share, with turnover of $9,019.85, pushing the stock back above its $60 IPO price.

On the news front, the stock has been experiencing sustained wide-range oscillation since multiple Wall Street investment banks initiated coverage on June 29. Target prices diverge significantly, ranging from $78 at Morgan Stanley (Equalweight) to $155 at Rosenblatt (Buy), with JPMorgan at $97 (Overweight), BofA at $100 (Buy), UBS at $93 (Buy), and Jefferies at $90 (Buy). The wide spread in valuations reflects fundamental uncertainty around the company, which reported Q1 revenue of just $5.24 million — down 73% year-over-year — with net losses widening to $136.5 million. Listed only since early June at $60 per share, Quantinuum is a full-stack quantum computing platform company integrating hardware, middleware, and application software for real-world deployment. Price volatility is likely to persist given the early-stage fundamentals and broad analyst disagreement.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)